Aims of the TAVI Registry

The Transcatheter Aortic Valve Implantation (TAVI) Registry is a clinical quality registry whose development is supported by the Australasian Cardiac Outcomes Registry (ACOR) Ltd as part of quality control and monitoring of procedural and clinical outcomes of patients undergoing aortic valve replacement via a transcatheter approach.

TAVI is an interventional procedure used for the treatment of aortic stenosis for patients that are deemed as high risk or inoperable. Guidelines produced by the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS ) and the Cardiac Society of Australia and New Zealand (CSANZ), titled ‘Position Statement for the Operator and Institutional Requirements for a Transcatheter Aortic Valve Implantation (TAVI) Program’, are the basis for institution and operator credentialing within Australia. Key points specified in these guidelines include the need for a multi-disciplinary team of professionals to oversee the governance, decision making and outcomes of institutional TAVI programs as well as institution participation in outcome monitoring in the form of a national TAVI Registry (TAVIR).

Specifically, the Registry aims to:

  • Improve patient care and outcomes
  • Educate clinicians and healthcare providers
  • Identify areas of excellence and opportunities for improvement
  • Ensure sites and clinicians meet the accreditation requirements to undertake TAVI procedures
  • Provide an accurate and transparent assessment of the safety of the TAVI procedure and devices